Until today, the United States Drug Enforcement Agency (the “DEA”) has prohibited telemedicine prescribing of controlled substances unless the provider had previously seen the patient in a traditional in‑person physical encounter, or under other various narrow circumstances. But today, the DEA invoked their emergency authority at 21 U.S.C. § 802(54)(D) to permit telemedicine prescribing of…Read More
COVID-19 Results in Removal of DEA Controlled Substance Prescribing Limitations for Telemedicine
Posted on March 17, 2020 in Health Law News
Published by: Hall Render